Discover 2,271 paid clinical trials in Oakland, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,271
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
for
Accelerated Phase Myeloproliferative Neoplasm,
Location: Palo Alto CA, Sacramento CA, Orange CA, Irvine CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06661915
Phase2, Recruiting
Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma
for
Relapsed or Refractory T Cell Lymphoma
Location: Palo Alto CA, Duarte CA, Orange CA, Portland OR,
Sponsor: Ono Pharmaceutical Co. Ltd
Sex: All
Age: 18+
Code: NCT05079282
Phase1, Recruiting
Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Palo Alto CA, La Jolla CA, Dallas TX, San Antonio TX,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT05007782
Phase1, Recruiting
Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
Location: Palo Alto CA, Buffalo NY, Philadelphia PA
Sponsor: Fox Chase Cancer Center
Sex: All
Age: 18+
Code: NCT05274048
Phase1, Recruiting
64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)
for
Prostatic Neoplasms, Castration-Resistant
Location: Stanford CA, Omaha NE, Rochester MN, St Louis MO,
Sponsor: Clarity Pharmaceuticals Ltd
Sex: Male
Age: 18+
Code: NCT04868604
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
for
Geographic Atrophy (GA),
Location: Walnut Creek CA, Sacramento CA, Reno NV, Bakersfield CA,
Sponsor: ONL Therapeutics
Sex: All
Age: 55+
Code: NCT06659445
Phase2, Recruiting
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Location: Palo Alto CA, Sacramento CA, Los Angeles CA, Irvine CA,
Sponsor: Aptose Biosciences Inc.
Sex: All
Age: 18+
Code: NCT03850574
Phase1, Phase2, Recruiting
Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors
for
Advanced Solid Tumors
Location: Palo Alto CA, San Antonio TX, Toronto, Fairfax VA,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT06532565
Phase1, Recruiting
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
for
Urinary Bladder Neoplasms, Neoplasm Metastasis,
Location: Stanford CA, Sacramento CA, Los Angeles CA, Duarte CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT05614739
Phase1, Recruiting
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
for
Gastrointestinal Stromal Tumor (GIST),
Location: Palo Alto CA, Santa Monica CA, Los Angeles CA,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06655246
Phase1, Recruiting
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
for
Relapsed/Refractory Multiple Myeloma
Location: Palo Alto CA, Milwaukee WI, Chicago IL, Atlanta GA,
Sponsor: Ichnos Sciences SA
Sex: All
Age: 18+
Code: NCT05862012
Phase1, Recruiting
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
for
Myeloproliferative Neoplasms
Location: Palo Alto CA, Salt Lake City UT, Phoenix AZ, Denver CO,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07008118
Phase1, Recruiting
Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma
for
Relapsed and/or Refractory B-cell Lymphoma
Location: Stanford CA, Duarte CA, Gilbert AZ, Austin TX,
Sponsor: Kite, A Gilead Company
Sex: All
Age: 18+
Code: NCT04989803
Phase1, Phase2, Recruiting
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)